MX9707006A - Estratrienos de 17-difluorometileno. - Google Patents
Estratrienos de 17-difluorometileno.Info
- Publication number
- MX9707006A MX9707006A MX9707006A MX9707006A MX9707006A MX 9707006 A MX9707006 A MX 9707006A MX 9707006 A MX9707006 A MX 9707006A MX 9707006 A MX9707006 A MX 9707006A MX 9707006 A MX9707006 A MX 9707006A
- Authority
- MX
- Mexico
- Prior art keywords
- hydrogen atom
- oestratrienes
- difluoromethylene
- beta
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Photoreceptors In Electrophotography (AREA)
- Exhaust-Gas Circulating Devices (AREA)
- Electrical Control Of Air Or Fuel Supplied To Internal-Combustion Engine (AREA)
- Saccharide Compounds (AREA)
- Vehicle Body Suspensions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Ceramic Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion describe nuevos estratienos de 17-difluorometileno de la formula general I, en donde significa: R1 un átomo de hidrogeno o un grupo alquilo con de 1 a 10 átomos de carbono, R5 un grupo metilo o etilo; R2 un átomo de hidrogeno o un grupo alquilo alfa o beta estable con de 1 a 10 átomos de carbono; R3 un grupo alquiloxi alfa o beta estable de 1 a 10 átomos de carbono o hidrogeno; R4 un átomo de hidrogeno alfa o beta estable, así como; A, B, D, E y G, cada uno un átomo de hidrogeno, así como dado el caso adicionalmente cuando menos uno de los pares de sustituyentes G y R2, R2 y R4, R4 y A, A y R3, B y D, D y E un enlace doble. Los nuevos compuestos presentan propiedades antioxidantes y vasculoprotectoras hasta ahora no descritas para los esteroides y son adecuados para la preparacion de preparados farmacéuticas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19509729A DE19509729A1 (de) | 1995-03-13 | 1995-03-13 | 17-Difluormethylen-Estratriene |
DE19509729.7 | 1995-03-13 | ||
PCT/EP1996/001069 WO1996028462A1 (de) | 1995-03-13 | 1996-03-13 | 17-difluormethylen-estratriene |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9707006A true MX9707006A (es) | 1997-11-29 |
MXPA97007006A MXPA97007006A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
CA2215201A1 (en) | 1996-09-19 |
DE59606435D1 (de) | 2001-03-22 |
SI9620030A (sl) | 1998-02-28 |
HUP9801846A3 (en) | 1999-03-01 |
RU2155770C2 (ru) | 2000-09-10 |
US6136800A (en) | 2000-10-24 |
NO974206L (no) | 1997-11-13 |
NO974206D0 (no) | 1997-09-12 |
CZ281097A3 (cs) | 1998-02-18 |
AU693335B2 (en) | 1998-06-25 |
WO1996028462A1 (de) | 1996-09-19 |
SK121697A3 (en) | 1998-02-04 |
ATE199159T1 (de) | 2001-02-15 |
TR199700950T1 (xx) | 1998-02-21 |
US6018062A (en) | 2000-01-25 |
BR9612787A (pt) | 1999-11-23 |
DE19509729A1 (de) | 1996-09-19 |
ZA962037B (en) | 1996-09-25 |
PL322199A1 (en) | 1998-01-19 |
IS4556A (is) | 1997-09-08 |
AU5107896A (en) | 1996-10-02 |
EP0815120A1 (de) | 1998-01-07 |
IL117497A0 (en) | 1996-07-23 |
JPH11501644A (ja) | 1999-02-09 |
IL117497A (en) | 1999-12-22 |
EP0815120B1 (de) | 2001-02-14 |
NO308306B1 (no) | 2000-08-28 |
HUP9801846A2 (hu) | 1998-12-28 |
KR19980703002A (ko) | 1998-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG100951A (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
TW325458B (en) | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer | |
DE3564566D1 (en) | Quinone derivatives, method and use of preparing same, and pharmaceutical composition | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
CA2243504A1 (en) | New 19-nor-pregnene derivatives | |
TR199700727T1 (xx) | Farnesil transferaz�n�n yeni inhibit�rleri. | |
IL73893A (en) | 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
TR199901578T2 (xx) | Klaritromisin form 0 kristali | |
MX9701538A (es) | Sales de un derivado del indol contra la migraña. | |
TW352382B (en) | Substituted sulfonimidamides, processes for their preparation, their use as a medicament of diagnostic, and medicament comprising them | |
MX9805181A (es) | Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano. | |
IL112622A0 (en) | Camptothecin derivatives, their preparation and pharmaceutical compositions containing them | |
HUP9800291A2 (hu) | Amido-pirimidin-származékok alkalmazása a glükóz metabolizmus megromlásának inhibiálására szolgáló gyógyászati készítmények előállítására | |
EP0394496A4 (en) | Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers | |
MD970313A (en) | New cryptophycines prepared by means of synthesis | |
CA2080249A1 (en) | Preparation of substituted piperidines | |
AU1436097A (en) | Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them | |
CA2155018A1 (en) | C7 taxane derivatives and pharmaceutical compositions containing them | |
MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0001827A2 (hu) | Kolchicin-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények, és a vegyületek alkalmazása gyógyszerkészítmények előállítására | |
ES2027550A6 (es) | Procedimiento para preparar derivados de glicerol. | |
UA41871C2 (uk) | Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі | |
MX9707006A (es) | Estratrienos de 17-difluorometileno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |